Skip to Content

EXPLAINER: Why Pfizer needs time to make COVID-19 treatment

<i></i><br/>
KMIZ

By TOM MURPHY
AP Health Writer

Pfizer’s new COVID-19 treatment came with a catch when it debuted late last year: It can take months to make the tablets. Company leaders say they have since expanded production and expect big gains in the next several months. That could help if another wave of cases develops later this year. The drugmaker uses more than 20 different sites in over 10 countries to produce Paxlovid. Making the complex drug involves chemical reactions that need time to develop. Pfizer says it has reduced production time from nearly nine months to about seven.

Article Topic Follows: AP National Business

Jump to comments ↓

associatedpress

BE PART OF THE CONVERSATION

ABC 17 News is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.

Skip to content